Related Experiment Video

Updated: Jan 30, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.8K

Molecular Mechanisms Related to Hormone Inhibition Resistance in Prostate Cancer

Veronica Mollica1, Vincenzo Di Nunno2, Alessia Cimadamore3

  • 1Division of Oncology, S. Orsola-Malpighi Hospital, Bologna 40138, Italy. veronica.mollica7@gmail.com.

Cells
|January 16, 2019
PubMed

Insights

Advanced prostate cancer treatments face resistance, driving research into new therapeutic pathways. Understanding hormone resistance mechanisms is key to developing novel drugs for improved patient outcomes.

Area of Science:

  • Oncology
  • Endocrinology
  • Pharmacology

Background:

  • Metastatic and advanced prostate cancer management has evolved with hormone-based therapies.
  • Prostate cancer's sensitivity to hormone depletion enables treatments inhibiting hormone production or nuclear receptor binding.
  • Hormonal therapies are standard for advanced prostate cancer, but resistance inevitably develops.

Purpose of the Study:

  • To investigate the mechanisms underlying resistance to hormone inhibition in advanced prostate cancer.
  • To identify novel therapeutic targets and drug development strategies.
  • To improve clinical outcomes for patients with advanced or metastatic prostate cancer.

Main Methods:

  • Review of current therapeutic approaches for metastatic and advanced prostate cancer.
  • Analysis of established hormonal treatments and their limitations.
  • Exploration of emerging research on resistance mechanisms.

Main Results:

  • Hormonal therapies, while effective, are ultimately overcome by treatment resistance.
  • Understanding resistance mechanisms is crucial for therapeutic advancement.
  • Identification of new pathways may lead to more effective treatments.

Conclusions:

  • Resistance to hormone inhibition is a critical challenge in advanced prostate cancer management.
  • Further research into resistance mechanisms is essential for developing next-generation therapies.
  • Targeting these mechanisms holds promise for improving patient survival and quality of life.
Keywords:
AR splice variantsepigenetic mechanismshormone inhibition resistanceprostate cancer (PCa), castration-resistance PCa

More Related Videos

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

14.0K
Isolation of Cancer Stem Cells From Human Prostate Cancer Samples07:16

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples

Published on: March 14, 2014

14.6K

Related Concept Videos

Hormonal Regulation01:40

Hormonal Regulation

Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
48.1K
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
36.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Types of Hormones02:13

Types of Hormones

Hormones can be classified into three main types based on their chemical structures: steroids, peptides, and amines. Their actions are mediated by the specific receptors they bind to on target cells.
83.5K
Plant Hormones01:56

Plant Hormones

Plant hormones—or phytohormones—are chemical molecules that modulate one or more physiological processes of a plant. In animals, hormones are often produced in specific glands and circulated via the circulatory system. However, plants lack hormone-producing glands.
27.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.1K